Centerpulse/Sulzer Medica seeks extension
This article was originally published in Clinica
Executive Summary
Sulzer Medica, now renamed Centerpulse, is confident it can substantially reduce the opt-out rate concerning its US settlement agreement and, together with the class plaintiffs, has asked for an extension for the final decision until May 31.